Home > Insider Trading > Filing (0001438588-13-000069)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
791908	Xoma Corp	XOMA	Pharmaceutical Preparations (2834)	942756657

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222790	Phd Md J Patrick Scannon	C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710	Exec. Vp & Cso	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2013-06-11	10,000	$1.69	27,448	No	4	M	Direct
Common Shares	Disposition	2013-06-11	10,000	$0.00	17,448	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Incentive Share Option (right to buy)	Disposition	2013-06-11	10,000	$0.00	10,000	$1.69

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,274		2021-10-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	20,339	Indirect	by 401(k)
Common Shares	750	Indirect	by Daughter
Common Shares	4,053	Indirect	by Trust

Footnotes

This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.
These shares were disposed of in multiple transactions at prices ranging from $4.00 to $4.08 for aggregate gross proceeds of $40,320.00, of which $16,900.00 was used to pay the option exercise price.
Taken together, the Incentive Stock Option and Non-Qualified Stock Option granted on the same date are exercisable as to 70% of the options on grant date, with the remaining 30% vesting in monthly increments beginning 11/28/2011 and ending 10/28/2013.